NeoGenomics, Inc.

Healthcare

NASDAQ:NEO · NASDAQ Capital Market

Market Cap $289.85M Beta 1.81 P/E (TTM) -2.9

$11.13 +6.03%

+$0.63 today

52W Low $4.72High $13.74

Vol 6.30M · Avg 1.94M

EPS (TTM) -$3.84Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+58.77%

Period High

$13.22

Period Low

$4.84

Latest

$11.13

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Aclaris Therapeutics, Inc.

NASDAQ:ACRS

$533.63M

Alpha Teknova, Inc.

NASDAQ:TKNO

$277.45M

Sagimet Biosciences Inc.

NASDAQ:SGMT

$216.99M

Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

$211.61M

Sanara MedTech Inc.

NASDAQ:SMTI

$198.81M

Stereotaxis, Inc.

AMEX:STXS

$178.37M

Humacyte, Inc.

NASDAQ:HUMA

$156.07M

Quanterix Corporation

NASDAQ:QTRX

$152.86M

Exagen Inc.

NASDAQ:XGN

$105.58M

MDxHealth S.A.

MDXH

$28.53M

What is the latest NEO filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does NEO have?

Intrinsic Alpha currently shows 20 recent filings for NEO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.